Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$18M
3 rounds on record
Latest round
$16M
Venture round · Nov 2022 · 3 yr ago
Team
4
US Form 5500 (plan participants) · Dec 2025 · -20% in a year
Backers
1
Xontogeny
The money's age
Long since its last round
46 months since the last round · not hiring
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 5%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Nov 2022 $16M — SEC Form D
Venture round May 2021 $2M — SEC Form D
Debt Financing Jan 2019 $75k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Tellus Therapeutics, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Jason KarlicExecutive Officer, DirectorSEC Form D
Eric BennerExecutive Officer, DirectorSEC Form D
Jason KralicExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
CellusionSeries C $2.8B · 3 yr ago • 1001-5000 employees
Cellusion develops regenerative medicine therapies using induced pluripotent stem (iPS) cells focused on treating corneal endothelial…
Discover Regenerative Medicine with D&P Bioinnovations. Transformative solutions for healing damaged tissues. Call us.
ExthymicVenture round $10.2M · 2 yr ago • Founded 2023 • 51-200 employees • 2 roles
We bring cell therapies to patients through innovative point-of-care manufacturing solutions.
REPROSENT creates the human-signal layer in oncology, turning patient symptoms into computable data for safer, more precise treatment…
AlerjeVenture round $1.9M · 3 yr ago • Founded 2016
FAIT connects clinics and families through the allergy treatment journey with AI powered insights, proactive monitoring, and seamless…
CereVasc eShunt® Device | Under Development for HydrocephalusVenture round $11.1M · 6 yr ago • Founded 2020 • 51-200 employees
The CereVasc eShunt® device is intended to improve patient outcomes and redefine the treatment of communicating hydrocephalus.

Overview

Transforming Care Within and Beyond the NICU. Tellus Therapeutics was founded on a singular mission: to bring hope and healing to the most vulnerable patients – premature infants facing life-altering brain and gut injuries with no treatment options.

People

Jason Karlic
Executive Officer, Director
Eric Benner
Executive Officer, Director
Jason Kralic
Executive Officer, Director
Alex Ruckdaeschel
Director
Fred Callori
Director
Chris Garabedian
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Hillsborough United States
HQ
Durham United States
Regional office
8 Davis Drive, Suite 220. Durham. NC. 27713
8 Davis Drive, Suite 220. Durham. NC. 27713
company site

Financials

Total raised
$18.1M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2022 $16M Details
Venture - Series Unknown 2021 $2M Details
Debt Financing 2019 $75k Details